These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 24362548)

  • 41. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interplay between microRNAs and the epigenetic machinery: an intricate network.
    Iorio MV; Piovan C; Croce CM
    Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The epigenetics of autoimmunity.
    Meda F; Folci M; Baccarelli A; Selmi C
    Cell Mol Immunol; 2011 May; 8(3):226-36. PubMed ID: 21278766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. microRNA-34a as a Therapeutic Agent against Human Cancer.
    Saito Y; Nakaoka T; Saito H
    J Clin Med; 2015 Nov; 4(11):1951-9. PubMed ID: 26580663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
    Pajares MJ; Alemany-Cosme E; Goñi S; Bandres E; Palanca-Ballester C; Sandoval J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetics and MicroRNAs in Cancer.
    Ramassone A; Pagotto S; Veronese A; Visone R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current paradigms in epigenetic anticancer therapeutics and future challenges.
    Singh M; Kumar V; Sehrawat N; Yadav M; Chaudhary M; Upadhyay SK; Kumar S; Sharma V; Kumar S; Dilbaghi N; Sharma AK
    Semin Cancer Biol; 2022 Aug; 83():422-440. PubMed ID: 33766649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic aberrations during oncogenesis.
    Hatziapostolou M; Iliopoulos D
    Cell Mol Life Sci; 2011 May; 68(10):1681-702. PubMed ID: 21249513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.
    Suzuki H; Maruyama R; Yamamoto E; Niinuma T; Kai M
    Adv Exp Med Biol; 2016; 927():109-35. PubMed ID: 27376733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic regulation of microRNAs in cancer: an integrated review of literature.
    Kunej T; Godnic I; Ferdin J; Horvat S; Dovc P; Calin GA
    Mutat Res; 2011 Dec; 717(1-2):77-84. PubMed ID: 21420983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
    Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
    Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic targets in human neoplasms.
    Fandy TE; Gore SD
    Epigenomics; 2010 Apr; 2(2):221-32. PubMed ID: 22121872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer.
    Ban HS; Han TS; Hur K; Cho HS
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of Dysregulated DNA Methylation to Autoimmunity.
    Funes SC; Fernández-Fierro A; Rebolledo-Zelada D; Mackern-Oberti JP; Kalergis AM
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?
    Jeffries MA; Sawalha AH
    Expert Rev Clin Immunol; 2015 Jan; 11(1):45-58. PubMed ID: 25534978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primer: epigenetics of autoimmunity.
    Richardson B
    Nat Clin Pract Rheumatol; 2007 Sep; 3(9):521-7. PubMed ID: 17762851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetic regulation of gene expression as an anticancer drug target.
    Ferguson LR; Tatham AL; Lin Z; Denny WA
    Curr Cancer Drug Targets; 2011 Feb; 11(2):199-212. PubMed ID: 21158714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.